Preventing Cognitive Decline with Metformin

Clinical trial NCT04511416 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04511416
Sponsor: Garvan Institute of Medical Research
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cognitive Decline

Start date: 2022-07-15
Primary completion: 2027-12-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.